The European Society for Translational Medicine (EUSTM) cordially invites industry partners to attend and apply for the sponsorship opportunities for the 9th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patients Care (EUSTM-2022) which will be held Virtual during 3-5 October, 2022. This Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care.
EUSTM-2022 not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.